AstraZeneca cuts UK headcount and moves to Cambridge

20 March 2013

Professor John Hardy (UCL Institute of Neurology) described AstraZeneca’s reduction of its UK headcount as “a terrible blow to the UK pharmaceutical industry” born of the company’s short-termism and “a hostile regulatory climate towards animal - especially rodent – work”. Read: THE